Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in HELLP I Syndrome
NCT01138839Phase 3Unknown
- Sponsor
- Universidad del Valle
- Start
- Oct 2009
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in HELLP syndrome (HELLP) comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Duration of hospitalization at 15 days. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
HELLP syndrome (HELLP)
Beyond the preview
Go deeper on NCT01138839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138839.